Difficulty: Medium
Average Score: 92%
Practice
The following antiamoebic drug should not be used in children because of risk of causing blindness
Correct answer
A
Rationale
In this question, the correct answer is A) Quinidochlor. Quinidochlor should not be used in children because it can cause blindness due to toxic optic neuritis. This adverse effect is particularly risky in children, thus making it unsuitable for pediatric use.
Option B) Diloxanide furoate is an antiprotozoal drug used to treat amoebiasis, but it does not carry the risk of causing blindness in children. Option C) Tinidazole is an antiamoebic drug commonly used to treat infections such as giardiasis and trichomoniasis. While it may have side effects, blindness is not a known adverse effect of Tinidazole. Option D) Secnidazole is another antiamoebic drug that does not have the risk of causing blindness in children.
Educationally, understanding the contraindications and potential adverse effects of chemotherapy drugs is crucial for healthcare professionals, especially when administering medications to vulnerable populations like children. This question highlights the importance of drug safety and the need for healthcare providers to be aware of specific risks associated with different medications to ensure safe and effective treatment.
Option B) Diloxanide furoate is an antiprotozoal drug used to treat amoebiasis, but it does not carry the risk of causing blindness in children. Option C) Tinidazole is an antiamoebic drug commonly used to treat infections such as giardiasis and trichomoniasis. While it may have side effects, blindness is not a known adverse effect of Tinidazole. Option D) Secnidazole is another antiamoebic drug that does not have the risk of causing blindness in children.
Educationally, understanding the contraindications and potential adverse effects of chemotherapy drugs is crucial for healthcare professionals, especially when administering medications to vulnerable populations like children. This question highlights the importance of drug safety and the need for healthcare providers to be aware of specific risks associated with different medications to ensure safe and effective treatment.